Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Short Interest Up 6.0% in October

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 1,230,000 shares, a growth of 6.0% from the September 30th total of 1,160,000 shares. Based on an average trading volume of 341,700 shares, the days-to-cover ratio is currently 3.6 days. Approximately 2.2% of the company's stock are short sold.

Analysts Set New Price Targets

Several research firms recently commented on AVAH. UBS Group lifted their price objective on Aveanna Healthcare from $1.70 to $2.80 and gave the stock a "sell" rating in a report on Friday, August 9th. Royal Bank of Canada lifted their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a "sector perform" rating in a report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a "buy" rating in a report on Friday, August 9th.

Aveanna Healthcare Stock Up 0.2 %

Shares of Aveanna Healthcare stock traded up $0.01 during trading hours on Wednesday, reaching $4.91. 123,771 shares of the stock traded hands, compared to its average volume of 188,474. The company has a 50 day moving average price of $5.21 and a 200 day moving average price of $3.80. The firm has a market capitalization of $948.73 million, a price-to-earnings ratio of -7.44 and a beta of 2.12. Aveanna Healthcare has a one year low of $1.34 and a one year high of $5.95.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.03. The firm had revenue of $504.96 million for the quarter, compared to the consensus estimate of $494.02 million. Sell-side analysts anticipate that Aveanna Healthcare will post -0.09 earnings per share for the current year.

Institutional Investors Weigh In On Aveanna Healthcare

A number of large investors have recently made changes to their positions in AVAH. Creative Planning lifted its position in shares of Aveanna Healthcare by 21.3% during the 3rd quarter. Creative Planning now owns 48,502 shares of the company's stock valued at $252,000 after buying an additional 8,502 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Aveanna Healthcare during the 3rd quarter valued at about $101,000. Mackenzie Financial Corp lifted its position in shares of Aveanna Healthcare by 35.9% during the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company's stock valued at $126,000 after buying an additional 12,075 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of Aveanna Healthcare by 155.8% during the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company's stock valued at $438,000 after buying an additional 96,600 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its position in shares of Aveanna Healthcare by 176.6% during the 2nd quarter. Acadian Asset Management LLC now owns 81,275 shares of the company's stock valued at $222,000 after buying an additional 51,890 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.